Publications
210
Citations
1,216
Est. group size
~41
Recurring co-author estimate
Active years
9
Publishing since 2018
Typically publishes in teams of ~40 · 6% small-team papers (≤3 authors) · across 13 venues
- AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors
npj Precision Oncology · 2026
- Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas
Radiology Artificial Intelligence · 2026
- First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients
JCI Insight · 2025
- High-dose DFMO alters protein translation in neuroblastoma
Neoplasia · 2025
- High-dose DFMO alters protein translation in neuroblastoma
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Supplementary Table S2 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Supplementary Table S3 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Supplementary Table S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Data from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Supplementary Figure S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Supplementary Figure S2 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Supplementary Table S4 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Supplementary Table S5 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Supplementary Data S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
- Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Nature Medicine · 2025
- Neuro-Oncology×39
- Journal of Clinical Oncology×5
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Neuro-Oncology Pediatrics×4
- Nature Medicine×3
- Carl Koschmann
Medicine · University of Michigan
- Rajen Mody
Medicine · University of Michigan
- Chan Chung
Medicine · University of Michigan
- Akash Deogharkar
Medicine · University of Michigan
- Dana Messinger
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile